Michael Erdmann

24PUBLICATIONS

118CO-AUTHORS

Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmaceutical delivery technologies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jul 07, 2026

S1 guideline sweat gland carcinoma.

|May 26, 2026

Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool.

|Jan 22, 2026

Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapy.

Kristine E Mayer, Jessica C Hassel, Jannik Sambale

|Nov 18, 2025

The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche.

Laura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl

|Jul 18, 2025

Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics.

Lisa Cuba, Frank Dörje, Rafaela Kramer

|Jun 03, 2025

Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma.

Georg C Lodde, Jessica C Hassel, Imke von Wasielewski

Pageof 4

Frequent Collaborators

11 joint publications

Markus Vincent Heppt

11 joint publications

Carola Berking

Bastian Schilling

Dirk Schadendorf

Theresa Steeb

Jochen S Utikal

Christoph Wies

Wiebke Sondermann

Matthias Goebeler

Anja Wessely

Frequent Collaborators

11 joint publications

Markus Vincent Heppt

11 joint publications

Carola Berking

5 joint publications

Bastian Schilling

5 joint publications

Dirk Schadendorf